References
- Harris N L, Jaffe E S, Stein H, Banks P M, Chan J KC, Cleary M L, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361–1392
- Wong K F, Chan J K, Matutes E, McCarthy K, Ng C S, Chan C H, et al. Hepatosplenic gamma delta T-cell lymphoma: a distinctive aggressive lymphoma type. American Journal of Surgical Pathology 1995; 19: 718–726
- Belhadj K, Reyes F, Farcet J P, Tilly H, Bastard C, Angonin R, et al. Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report of a series of 21 patients. Blood 2003; 102: 4261–4269
- Weidmann E. Hepatosplenic T-cell lymphoma: a review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990. Leukemia 2000; 14: 991–997
- Zinzani P L, Tani M, Molinari A L, Stefoni V, Zuffa E, Alinari L, et al. Ifosfamide, epirubicin and etoposide regimen as salvage and mobilizing therapy for relapsed/refractory lymphoma patients. Haematologica 2002; 87: 816–821
- Klimo P, Connors J M. MACOP-B chemotherapy for the treatment of advanced diffuse large cell lymphoma. Annals of Internal Medicine 1985; 102: 596–602
- Farcet J P, Gaulard P, Marolleau J P, Le Couedic J P, Henni T, Gourdin M F, et al. Hepatosplenic T-cell lymphoma: sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta. Blood 1990; 75: 2213–2219
- Vega F, Medeiros L J, Bueso-Ramos C, Jones D, Lai R, Luthra R, Abruzzo L V. Hepatosplenic gamma/delta T-cell lymphoma in bone marrow: a sinusoidal neoplasm with blastic cytologic features. American Journal of Clinical Pathology 2001; 116: 410–419
- Cooke C B, Krenacs L, Stetler-Stevenson M, Greiner T C, Raffled M, Kingma D W, et al. Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin. Blood 1996; 88: 4265–4274
- Salhany K E, Feldman M, Kahn M J, Peritt D, Schretzenmair R D, Wilson D M, et al. Hepatosplenic gamma delta T-cell lymphoma: ultrastructural, immunophenotypic, and functional evidence for cytotoxic T lymphocyte differentiation. Human Pathology 1997; 28: 674–685
- Jonveaux P, Daniel M T, Martel V, Maarek O, Berger R. Isochromosome 7q and trisomy 8 hepatosplenic T gamma/delta lymphoma. Leukemia 1996; 10: 1453–1455
- Salhany K E, Feldman M, Peritt D, Nowell P C. Cytotoxic T-lymphocyte differentiation and are consistent primary, non-random chromosomal abnormalities associated with cytogenetic alterations in gamma delta hepatosplenic T-cell lymphoma and posttransplant lymphoproliferative disorders. Blood 1997; 89: 3490–3491
- Khan W A, Yu L, Eisenbrey A B, Crisan D, al Saadi A, Davis B H, et al. Hepatosplenic gamma/delta T-cell lymphoma in immunocompromised patients: report of two cases and review of literature. American Journal of Clinical Pathology 2001; 116: 41–50
- Gassas A, Kirby M, Weitzman S, Ngan B, Abla O, Doyle J J. Hepatosplenic gammadelta T-cell lymphoma in a 10 year old boy successfully treated with hemopoietic bone marrow transplantation. American Journal of Hematology 2004; 75: 113–114
- Ooi J, Iseki T, Adachi D, Yamashita T, Tomonari A, Tojo A, et al. Successful allogeneic bone marrow transplantation for hepatosplenic T-cell lymphoma. Haematologica 2001; 86: E25
- Grigg A P. 2'-Deoxycoformycin for hepatosplenic T-cell lymphoma. Leukemia and Lymphoma 2001; 42: 797–799
- Iannitto E, Barbera V, Quintini G, Cirrincione S, Leone M. Hepatosplenic T-cell lymphoma: complete response induced by treatment with pentostatin. British Journal of Haematology 2002; 117: 995–996